Department of Biochemistry and the Center for
Advanced Molecular Biology and Immunology, School of Medicine and
Biomedical Sciences, State University of New York at Buffalo, Buffalo,
New York 14214-3000
The general transcription factor IIB (TFIIB) is required for
transcription of class II genes by RNA polymerase II. Previous studies
demonstrated that mutations in the Saccharomyces cerevisiae SUA7 gene, which encodes TFIIB, can alter transcription
initiation patterns in vivo. To further delineate the functional domain
and residues of TFIIB involved in transcription start site utilization, a genetic selection was used to isolate S. cerevisiae TFIIB
mutants exhibiting downstream shifts in transcription initiation in
vivo. Both dominant and recessive mutations conferring downstream
shifts were identified at multiple positions within a highly conserved homology block in the N-terminal region of the protein. The TFIIB mutations conferred downstream shifts in transcription initiation at
the ADH1 and CYC1 promoters, whereas no
significant shifts were observed at the HIS3 promoter.
Analysis of a series of ADH1-HIS3 hybrid promoters and
variant ADH1 and HIS3 promoters containing insertions, deletions, or site-directed base substitutions revealed that the feature that renders a promoter sensitive to TFIIB mutations is the sequence in the immediate vicinity of the normal start sites. We
discuss these results in light of possible models for the mechanism of
start site utilization by S. cerevisiae RNA polymerase II
and the role played by TFIIB.
 |
INTRODUCTION |
Accurate and efficient transcription
of eukaryotic protein-coding (class II) genes involves the concerted
action of RNA polymerase II (RNAPII) and a host of accessory proteins.
A subset of these proteins are known as the general transcription
factors (GTFs) and include TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH
(reviewed in reference 34). The GTFs are being
intensively studied with the objective of determining their
respective functions during the different stages of RNAPII
transcription, which include (i) formation of a preinitiation complex
(PIC) on the promoter, (ii) melting of the promoter DNA, (iii)
transcription initiation, (iv) clearance of RNAPII from the promoter,
(v) elongation of the nascent transcript, and (vi) transcription termination.
Most promoters of class II genes contain both upstream regulatory
elements and TATA elements. TATA elements, containing the consensus
sequence TATAa/tAa/t, are located upstream of the mRNA start sites and
are specific binding sites for the TATA-binding protein (TBP) subunit
of TFIID (32, 36). For most class II promoters, formation
of an active PIC is thought to occur by the initial binding of TFIID to
the TATA element, in some cases accompanied by TFIIA. It is proposed
that PIC formation then proceeds by either an ordered stepwise
association of the remaining factors and RNAPII or by the direct
recruitment of RNAPII holoenzyme (reviewed in reference
34). Upon PIC formation, the promoter DNA can be melted in
an energy-dependent step, facilitating the initiation of mRNA synthesis
and clearance of RNAPII from the promoter. In higher eukaryotes,
transcription initiation usually occurs at a discrete start site
located about 25 to 30 bp downstream of the TATA element. In contrast,
transcription initiation in the yeast Saccharomyces cerevisiae frequently occurs at multiple sites within a window of
45 to 120 bp downstream of the TATA element (reviewed in references 17 and 45).
TFIIB plays an essential role in RNAPII transcription. The TFIIB
polypeptide comprises a protease-sensitive N-terminal region that is
highly conserved, followed by a protease-resistant C-terminal core
domain that contains two imperfect direct repeats (2, 4, 31,
33). The N-terminal region contains a putative zinc-ribbon motif
(W. Zhu, Q. Zeng, C. M. Colangelo, M. Lewis, M. F. Summers, and R. A. Scott, Letter, Nat. Struct. Biol. 3:122-124, 1996) and is required for interaction with TFIIF and RNAPII (3, 9, 12, 18, 35). The C-terminal core domain binds TBP (8, 18, 30) and the TBP-associated factor TAF40
(16) and interacts with DNA both immediately
upstream and downstream of the TATA element (25,
26). In light of these multiple sets of interactions, TFIIB is
often viewed as a bridging factor between promoter-bound TFIID and the
remainder of the general transcription machinery. TFIIB may also play a
role in the response to transcriptional activator proteins, as
mutations in both the N-terminal and the C-terminal domains that
reportedly impair activation have been identified (40, 42, 43,
47) and many transcriptional activator proteins directly bind
TFIIB (10, 11, 13, 19, 28, 29, 41, 48).
In S. cerevisiae, TFIIB is encoded by the SUA7
gene. SUA7 was initially identified and characterized by
Hampsey and coworkers in a suppressor analysis of respiration-deficient
strains that contained an aberrant ATG translational initiation codon
in the leader region of the CYC1 gene (cyc1-5000)
(37). In those studies, two sua7 mutations that
mapped to the N-terminal region of the protein and suppressed the
respiration-deficient phenotype by conferring a downstream shift in
transcription initiation at cyc1 were identified
(38). Subsequent structure-function studies of yeast TFIIB
have identified additional mutations in the N-terminal region of yeast
TFIIB that alter start site utilization (3, 35).
To further investigate the domain of S. cerevisiae TFIIB
involved in transcription start site utilization, we combined the genetic approach of Hampsey and coworkers with error-prone PCR and
plasmid-shuffling to directly select for TFIIB mutants that confer
downstream shifts in transcription initiation in vivo. The mutants
isolated in this selection, combined with previously identified mutants
altering start site utilization, define a highly conserved discrete
domain within the N-terminal region of TFIIB involved in transcription
start site recognition. To gain insight into the mechanism by which
TFIIB affects start site utilization, a series of variant
ADH1 and HIS3 promoters were constructed and analyzed in order to determine which feature of a promoter renders it
sensitive to TFIIB mutations that confer downstream shifts in
initiation. The results reported here demonstrate that the sensitivity
of a promoter to TFIIB mutations is determined by neither the upstream
regulatory elements, TATA elements, general promoter architecture, nor
intrinsic strength of the start sites but rather is dictated by the
identity of bases at or in the immediate vicinity of the normal
start sites.
 |
MATERIALS AND METHODS |
S. cerevisiae strains and media.
All
S. cerevisiae strains used in this study are derivatives of
S288C. Plasmid-shuffle strain FP227 (MAT
ura3-52 trp1
63 sua7
1 cyc1-5000 + [p316/yIIB(URA3)]) was
constructed by two-step gene replacement of the CYC1 gene in
strain FP153 (MAT
ura3-52 trp1
63 sua7
1 + [p316/yIIB(URA3)]) using the
cyc1-5000-integrating plasmid pSF13. For the analysis of the
effects of TFIIB mutations on ADH1-HIS3 hybrid promoters and
variant ADH1 and HIS3 promoters containing
insertions, deletions, or site-directed base substitutions, the
relevant ADH1 or HIS3 reporter plasmids (all
containing URA3 as a selectable marker) were transformed
into the following strains: FP251 (MAT
ura3-52 trp1
63
his3
200 lys2 sua7
1 + [p314/yIIB(TRP1)]); FP252 (MAT
ura3-52
trp1
63 his3
200 lys2 sua7
1 + [p314/V79L(TRP1)]); FP253 (MAT
ura3-52 trp1
63
his3
200 lys2 sua7
1 + [p314/R64G(TRP1)]); and
FP254 (MAT
ura3-52 trp1
63 his3
200 lys2 sua7
1 + [p314/E62G(TRP1)]). Complete lineages of strains are
available upon request.
Rich media (YPD plates and liquid) and 5-FOA (synthetic complete medium
containing 5-fluoroorotic acid) plates were prepared as described
previously (44). Casamino Acids medium (CAA) contained 0.6% Casamino Acids, 0.68% yeast nitrogen base without amino acids, 25 µg of adenine per ml, 25 µg of uracil per ml, 80 µg of
tryptophan per ml, either 2% glucose or 2% lactate, and 2% agar for
solid medium.
Plasmids.
Plasmid p314/yIIB-Mlu is a derivative of
p314/yIIB, which contains the entire SUA7 promoter and
coding region in the yeast-Escherichia coli shuttle vector
pRS314 (CEN6 TRP1) and has been described previously
(3). To generate p314/yIIB-Mlu, the megaprimer method of
PCR site-directed mutagenesis was used to introduce a unique MluI restriction site into the coding region at the position
corresponding to amino acids 94 and 95 with no resulting change in
protein sequence (1). Integrating plasmid pSF13,
containing the S. cerevisiae cyc1-5000 gene, was constructed
by replacing the 385-bp XmaI-EcoRI CYC1 promoter fragment in plasmid pM142 with the
corresponding fragment isolated from plasmid pM330 (5).
The construction of all ADH1 and HIS3 promoter
derivatives was based on plasmids p316/A and p316/H. Plasmid p316/A
contains the ADH1 promoter (fragment
500 to +12) fused to
the HIS3 coding region (fragment +1 to +900) in vector
pRS316 (CEN6 URA3). Plasmid p316/H contains the
HIS3 gene (fragment
440 to +900) cloned into the pRS316
vector. The two AT-rich elements in the ADH1 promoter in
p316/A (TATAAATA, positions
128 to
121, and
TATTAAT, positions
110 to
104) were converted to
XbaI sites by site-directed mutagenesis to generate plasmids
p316/D1 (
128) and p316/D2 (
110). To generate ADH1
promoter derivatives with variable distance between the TATA element
and the transcription start sites, MluI restriction sites were introduced at positions
52,
64,
80, or
92 of the
ADH1 promoter. The digestion and subsequent cloning of the
different ADH1 promoter fragments generated a battery of
pRS316-based plasmids containing 12-, 28-, and 40-bp deletions
(p316/A-12, p316/A-28, p316/A-40, respectively) or insertions
(p316/A+12, p316/A+28, p316/A+40, respectively) in the ADH1
promoter. The construction of the ADH1-HIS3 promoter
hybrids was based on the introduction of MluI restriction
sites in both the ADH1 and HIS3 promoters 14 bp
upstream from the first major transcription start site (position
52
in ADH1 and position
37 in HIS3). The
promoter fragment swap generated plasmids p316/AH (ADH1
promoter upstream of the HIS3 transcription initiation
region) and p316/HA (HIS3 promoter upstream of the
ADH1 initiation region). Plasmids p316/AH and p316/HA
were also used as templates in the PCR-based site-directed mutagenesis of the sequences adjacent to the transcription start sites.
Construction of mutant sua7 libraries.
The
entire SUA7 insert in plasmid p314/yIIB-Mlu was amplified by
PCR under error-prone conditions. Reaction mixtures (100 µl)
contained 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 0.01% gelatin, 7 mM
MgCl2, 1 mM MnCl2, 1 mM dCTP, 1 mM dTTP, 200 µM dATP, 200 µM dGTP, 200 ng of p314/yIIB-Mlu template, 100 pmol
each of the M13 forward and reverse primers, and 5 U of Taq
polymerase (Perkin-Elmer). Reactions were carried out for 30 cycles of
92°C for 1 min, 55°C for 1 min, and 72°C for 2 min. For the
construction of the N-terminal mutant library, the 1.9-kb PCR product
was digested with NdeI and MluI, and the
approximately 300-bp fragment (encoding amino acids 1 to 94) was gel
purified and cloned into the NdeI and MluI sites
of p314/yIIB-Mlu. For the construction of the C-terminal mutant
library, the 1.9-kb PCR product was digested with MluI and
PstI, and the approximately 900-bp fragment (encoding amino acids 95 to 345) was gel purified and cloned into the MluI
and PstI sites of p314/yIIB-Mlu. Approximately 25,000 primary E. coli transformants were obtained for each
library. Nucleotide sequencing of 10 randomly selected clones revealed
the mutation frequency to be on average one mutation per 200 bp.
Phenotypic analyses of mutant TFIIB strains.
Mutant
sua7 plasmids identified in the genetic selection were
reintroduced into strain FP227 by transformation, and the cells were
plated on CAA medium lacking uracil and tryptophan. The plates were
incubated for 3 days at 30°C to select for cells containing both the
mutant plasmid (TRP1-containing) and the endogenous plasmid containing the URA3 and SUA7 genes. The
Ura+ Trp+ transformants were then purified once
on CAA lacking Trp and uracil. To test for dominant growth phenotypes
on lactate-containing medium, the strains were streaked on CAA-lactate
lacking uracil and Trp, and the plates were incubated at 30°C for 9 days. To analyze the growth properties of strains containing the mutant sua7 plasmid as the sole source of TFIIB, the
Ura+ Trp+ strains were streaked on 5-FOA medium
and the plates were incubated at room temperature for 4 days.
5-FOA-resistant colonies were purified once by streaking on plates of
CAA without Trp and incubating the plates at room temperature for 3 to
4 days. The mutant strains were tested for their relative growth rates
on CAA-lactate medium without Trp (30°C for 7 to 10 days) and on rich
medium at high temperature (37°C for 3 days) and low temperature
(16°C for 4 days).
Mapping of in vivo mRNA start sites.
Plasmids containing
known TFIIB substitution mutants were introduced into strain FP153 by
transformation, and the endogenous plasmid containing wild-type TFIIB
was removed by plasmid shuffling on 5-FOA medium. To analyze
CYC1 transcripts, cells were grown in liquid CAA-lactate
medium lacking Trp and total RNA was prepared as described previously
(39). To analyze ADH1 and HIS3
transcripts, total RNA was prepared from cells grown in liquid
CAA-glucose medium lacking Trp. Primer extension analysis was carried
out using 30 µg of total RNA under conditions previously described (39). The oligonucleotide primer for the analysis of
CYC1 mRNA contained the sequence
5'-dGTCTTGAAAAGTGTAGCACC-3', corresponding to positions +53
to +34 (where +1 is the initiating ATG). The oligonucleotide primer for
the analysis of ADH1 mRNA contained the sequence
5'-dGTATTCCAACTTACCGTGGGATTCG-3', corresponding to positions
+63 to +39 (where +1 is the initiating ATG). To analyze transcripts
from the ADH1-HIS3 hybrid promoters and variant
ADH1 and HIS3 promoters containing insertions,
deletions, or site-directed base substitutions (all fused to the
HIS3 coding region), strains FP251 to FP254 containing the
relevant reporter plasmids were grown in liquid CAA medium without
uracil and total RNA was prepared and analyzed by primer extension. The
oligonucleotide primer contained the sequence
5'-dGGTTTCATTTGTAATACGC-3', corresponding to HIS3 positions +45 to +26 (where +1 is the initiating ATG).
 |
RESULTS |
Isolation of S. cerevisiae TFIIB mutants conferring
downstream shifts in transcription initiation.
To isolate TFIIB
mutants conferring alterations in transcription initiation, two mutant
sua7 libraries that contained substitutions in either the
highly conserved N-terminal region (residues 1 to 94) or the C-terminal
core domain (residues 95 to 345) were constructed. The libraries were
generated utilizing PCR amplification under error-prone conditions to
randomly introduce mutations into the SUA7 gene on a plasmid
containing the TRP1 gene as a selectable marker (see
Materials and Methods). The sua7 libraries were
independently introduced into strain FP227, which contains a
chromosomal deletion of the essential SUA7 gene, a plasmid
containing the URA3 and SUA7 genes to maintain
cell viability, and a chromosomal cyc1-5000 gene (Fig.
1). The cyc1-5000 mutation,
characterized by Hampsey and coworkers, contains an aberrant ATG
translational initiation codon positioned upstream and out of frame
with the normal CYC1 initiation codon (21). The
reduced amount of iso-1-cytochrome c in this strain results
in an inability to grow on media containing nonfermentable carbon
sources such as lactate. Importantly, downstream shifts in
transcription initiation can generate transcripts that initiate between
the aberrant and normal ATG codons, thereby partially restoring
iso-1-cytochrome c protein levels and conferring the ability
to grow on medium containing lactate as the sole carbon source
(37). For each sua7 library, approximately
7 × 105 Trp+ transformants of strain
FP227 were plated on medium lacking tryptophan and containing lactate
as the sole carbon source. After incubation at 30°C for 10 days,
approximately 70 colonies were observed with the N-terminal library and
approximately half that number for the C-terminal library. To determine
whether growth on lactate medium was conferred by a mutant
sua7 plasmid, plasmids containing the TRP1 gene
and a candidate sua7 gene were rescued (53 colonies from the
N-terminal library and 33 colonies from the C-terminal library) and
reintroduced into strain FP227, and the transformants were again tested
for growth on CAA/lactate-Trp. For the N-terminal library, 32 of the 53 rescued plasmids conferred the ability to grow on CAA-lactate medium
without Trp when retested, whereas 0 of 33 rescued plasmids from the
C-terminal library conferred the ability to grow on CAA-lactate without
Trp. These results suggest that the C-terminal core domain of
TFIIB does not play a significant role in the mechanism of start site
utilization.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 1.
Scheme used for the genetic selection of TFIIB mutants
that confer downstream shifts in transcription initiation in vivo.
|
|
To begin a characterization of the TFIIB mutants conferring growth on
CAA-lactate medium lacking Trp, the 32 isolated sua7 plasmids were sequenced. The results revealed the presence of 24 different mutant sua7 genes among these plasmids (Table
1). The mutant sua7 genes
contained single or multiple amino acid substitutions clustered to
residues Glu-62, Arg-64, Arg-78, and Val-79, with Arg-78 being the most
frequently altered residue. Among the 15 mutants with multiple amino
acid substitutions, 5 contained a mutation of Tyr-30, which included
Y30N, Y30D or Y30F substitutions. Interestingly, these substitutions
were always found in combination with a substitution at residue Arg-78
or Val-79.
To further characterize the TFIIB mutants, the growth properties of
strains containing the mutant plasmids were determined in either the
presence or the absence of wild-type TFIIB. Strain FP227 was
transformed with the 24 mutant plasmids, and the transformants were
plated on CAA medium lacking uracil and tryptophan to select for the
presence of both the mutant plasmid (containing TRP1) and
the plasmid containing SUA7 and URA3. The
Ura+ Trp+ transformants were initially tested
for their ability to grow on CAA medium lacking uracil and tryptophan
and containing lactate as the sole carbon source. Seventeen of the 24 mutants exhibited a dominant phenotype for growth on lactate-containing
medium in the presence of wild-type SUA7 (Table 1). These 17 mutants all contained substitutions at residue Arg-78 or Val-79. To
analyze the growth properties of strains containing only the mutant
sua7 plasmid, the Ura+ Trp+ strains
were plated on 5-FOA medium to select for cells that had lost the
URA3-containing plasmid with wild-type SUA7
(7). All 24 of the mutant strains gave rise to
5-FOA-resistant colonies, demonstrating that all of the mutants could
support at least minimal cell growth in the absence of wild-type TFIIB.
The mutant strains were then tested for their growth properties on
CAA-lactate medium lacking Trp as well as on rich medium at high
(37°C) and low (16°C) temperatures. As expected, all of the mutant
strains grew on CAA-lactate medium lacking Trp, confirming that the
seven mutants with substitutions at residue Glu-62 or Arg-64 exhibited
recessive phenotypes with respect to growth on lactate medium (Table
1). All of the mutants exhibited a cold-sensitive phenotype on rich
medium, consistent with the phenotype of previously isolated mutants
exhibiting downstream shifts in transcription initiation, while 10 mutants also exhibited a temperature-sensitive phenotype. In addition,
many of the mutants that displayed a dominant phenotype for growth on
lactate medium (substitutions at Arg-78 and Val-79) grew slower than
the recessive mutants (Table 1). In this regard, it was noteworthy that
mutant R78L grew slowly on YPD at 30°C, whereas the R78L/Y30D and
R78L/Y30N mutants grew significantly better. These results suggest a
possible functional relationship between residues Arg-78 and Tyr-30.
To directly analyze the effects of the TFIIB mutants on transcription
initiation, primer extension analysis was used to map the transcription
start sites at the CYC1 and ADH1 promoters in the
mutant strains. Eleven representative strains, each containing a mutant
sua7 plasmid as the sole source of TFIIB, were grown in
either liquid CAA-lactate medium lacking Trp (for analysis of
CYC1) or CAA-glucose medium lacking Trp (for analysis of
ADH1). Total RNA was prepared and analyzed by primer
extension using a CYC1-specific primer (Fig.
2A) or an ADH1-specific primer
(Fig. 2B). For both promoters, the results revealed a decreased
utilization of a major transcriptional start site proximal to the TATA
element, which was accompanied by more pronounced utilization of minor start sites further downstream from the TATA element. These results confirm that the TFIIB mutants confer downstream shifts in
transcription initiation at the CYC1 and ADH1
promoters in vivo. In contrast, no significant downstream shifts were
detected at the HIS3 promoter (Fig.
3B and data not shown), consistent with
previous observations (3, 5).

View larger version (55K):
[in this window]
[in a new window]
|
FIG. 2.
TFIIB mutations confer downstream shifts in
transcription initiation at the CYC1 and ADH1
promoters. Total RNA (30 µg) from yeast strains containing the
indicated TFIIB mutations were analyzed by primer extension utilizing a
CYC1-specific (A) or ADH1-specific (B)
oligonucleotide primer. The numbers to the left of each panel indicate
the major transcription start sites and the distance from the
translation-initiating ATG (+1).
|
|

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 3.
Differential effect of the V79L TFIIB mutation on
transcription initiation at the ADH1 and HIS3
promoters. Primer extension analyses were performed using an
ADH1-specific (A) or HIS3-specific (B) primer as
described in the legend to Fig. 2. The first four lanes in each panel
contain sequencing ladders of each promoter region (left to right: G,
A, T, C) obtained with the same primers used in the primer extension
analyses.
|
|
The ADH1 promoter contains a single functional TATA
element and both TFIIB-sensitive and TFIIB-insensitive major
transcription start sites.
The ADH1 promoter contains
three major transcription start sites. In our strains these sites map
to positions
37,
28, and
27 (where +1 corresponds to the
translation-initiating ATG) and an additional minor start site maps to
position
38. Although the TFIIB mutants clearly confer decreased
utilization of the
38 and
37 sites along with more pronounced
utilization of minor start sites further downstream, the utilization of
the
28 and
27 sites appears relatively constant in both wild-type
and mutant TFIIB strains (Fig. 2B and 3A). One possible explanation for
this result is that the ADH1 promoter contains two
functional TATA elements, one that directs initiation to the
38 and
37 sites and a more downstream TATA that directs initiation to the
28 and
27 sites. The relatively constant amount of the
28 and
27 transcripts could be explained by TFIIB mutations causing
downstream shifts for initiation directed by both the upstream and
downstream TATA elements. In this view, a downstream shift in
initiation directed by the more downstream TATA element would give rise
to the observed far-downstream transcripts as well as a reduction in
the amount of the
28 and
27 transcripts. However, a downstream shift for initiation directed by the more upstream TATA element would
give rise to a reduction in the amount of the
38 and
37 transcripts
along with an increase in the amount of the more downstream
28 and
27 transcripts, thereby restoring essentially wild-type levels of the
28 and
27 transcripts. Alternatively, the ADH1 promoter
could contain a single functional TATA element and the constant level
of the
28 and
27 transcripts might be due to these sites being
insensitive to the effects of the TFIIB mutations. To distinguish
between these possibilities, we sought to identify the functional TATA
element(s) in the ADH1 promoter. Examination of the sequence
upstream of the
38 start site revealed two potential TATA elements
located between positions
128 and
123 (TATAAA) and
between positions
110 and
105 (TATTAA) (Fig.
4A). Site-directed mutagenesis was
utilized to disrupt each of these motifs with the substitution of an
XbaI restriction site (Fig. 4A). To facilitate primer
extension analysis of the variant ADH1 promoters in strains containing a wild-type chromosomal ADH1 gene, plasmids that
contained the wild-type or mutant ADH1 promoters fused to
the HIS3 coding region were constructed. The plasmids were
then introduced into wild-type or mutant TFIIB strains that contained a
deletion of the chromosomal HIS3 gene. Primer extension
analysis of total RNA using a HIS3-specific primer revealed
that substitutions at positions
127 and
124 (D1) abolished all
detectable ADH1 transcription whereas substitutions at
positions
109,
107, and
106 (D2) had no detectable effect (Fig.
4B). These results demonstrate that the ADH1 promoter
contains a single functional TATA element located between positions
128 and
123 and suggest that the
38 and
37 start sites and the
28 and
27 start sites differ in their intrinsic sensitivity to the
effects of TFIIB mutations.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 4.
The ADH1 promoter contains a single
functional TATA element. (A) Sequence of the ADH1 promoter
region from positions 137 to 98 (where +1 corresponds to the
initiating ATG) and specific mutations introduced to disrupt the two
potential TATA elements (D1, D2). (B) Primer extension analyses were
performed using an ADH1-specific primer and 30 µg of total
RNA isolated from yeast strains containing the indicated
ADH1 promoter construct and either wild-type or mutant
(V79L) TFIIB. The last four lanes contain the sequencing ladder of the
ADH1 promoter obtained with the same primer used in the
primer extension analysis (left to right; G, A, T, C).
|
|
Analysis of ADH1-HIS3 hybrid promoters and
ADH1 promoters with altered distance between the TATA
element and the start sites.
Mutations in TFIIB can cause
downstream shifts in transcription initiation at the ADH1
promoter, whereas no significant shifts are detected at the
HIS3 promoter (Fig. 3B; data not shown) (3, 5).
To gain insight into the mechanism by which TFIIB mutants alter
transcription initiation, we sought to determine which features of the
ADH1 and HIS3 promoters render them susceptible
and insensitive, respectively, to downstream shifts. We initially
tested whether alterations in the spacing between the ADH1
TATA element and the start sites result in altered sensitivity to TFIIB
mutations. A series of variant ADH1 promoters containing
insertions or deletions of 12, 28, or 40 bp between the TATA element
and the start sites were constructed and introduced into both wild-type
and V79L mutant TFIIB strains (Fig. 5).
Primer extension analysis demonstrated that deletion of 12 or 28 bp or
insertion of 12, 28, or 40 bp between the TATA element and the
initiation region had no significant effect on the initiation pattern
in the wild-type TFIIB strain or on the downstream shifts observed for
the mutant strain (Fig. 5). Deletion of 40 bp resulted in a significant
reduction in the amount of the upstream
38 and
37 transcripts in
the wild-type TFIIB strain, but downstream transcripts were still
observed in the V79L strain (Fig. 5). The reduction in the amount of
the
38 and
37 transcripts in the 40-bp deletion construct was not
unexpected since the
38 and
37 sites in this construct are
positioned 50 bp downstream of the TATA element, close to the minimal
distance required between a yeast TATA element and an initiation
site. Nonetheless, these results suggest that the spacing between the ADH1 TATA element and the initiation region does not play a
significant role in determining the sensitivity of the start sites to
TFIIB mutations.

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 5.
Analysis of ADH1 promoters with altered
distances between the TATA element and the start sites. Primer
extension analyses were performed with variants of the ADH1
promoter containing insertions or deletions of 12, 28, or 40 bp. The
40 and +40 constructs contain a deletion and duplication,
respectively, of the region between positions 92 and 52. The 28
and +28 constructs contain a deletion and duplication, respectively, of
the region between positions 92 and 64. The 12 and +12 constructs
contain a deletion and duplication, respectively, of the region between
positions 92 and 80.
|
|
To further investigate which features of the ADH1 and
HIS3 promoters determine their susceptibility to downstream
shifts, reciprocal ADH1-HIS3 hybrid promoters were
constructed and analyzed. The HIS3 promoter contains two
major transcription start sites that in our yeast strains map to
positions
23 and
10, where +1 corresponds to the
translation-initiating ATG (Fig. 3B). The
10 start site is governed
by a traditional TATA element located at position
68, whereas the
23 start site is governed by the TC element, which
appears to contain several weak TATA elements located between positions
106 and
77 (24). Through the introduction of an
MluI restriction site 14 bp upstream of the ADH1
and HIS3 initiation regions, reciprocal HIS3-ADH1
and ADH1-HIS3 hybrid promoters that contain the start sites
from one promoter substituted at the position of the normal start sites
of the other promoter were constructed (Fig.
6A). Reporter plasmids containing the
ADH1, HIS3-ADH1, HIS3, or ADH1-HIS3
promoters were introduced into wild-type and TFIIB mutant strains, and
the transcripts were analyzed by primer extension. Compared to the
ADH1 promoter in the wild-type TFIIB strain, fusion of the
HIS3 sequences to the ADH1 initiation region
resulted in a significantly lower ratio of the amount of the
38 and
37 transcripts to the amount of the
28 and
27 transcripts (Fig.
6B, lanes 1 and 5). As noted above for the ADH1 40-bp
deletion construct, the reduction in the amount of the
38 and
37
transcripts in the HIS3-ADH1 promoter was expected since
these sites are positioned only 45 bp downstream of the HIS3
TATA element. The HIS3-ADH1 promoter also yielded lower
overall levels of transcripts in all strains tested, consistent with
the lower intrinsic activity of the HIS3 promoter.
Significantly, introduction of the ADH1 or HIS3-ADH1 promoters into the TFIIB mutant strains resulted
in a further reduction in the level of the
38 and
37 transcripts, which was accompanied by an increase in the amount of more-downstream transcripts (Fig. 6B). These results indicate that downstream shifts in
transcription initiation can occur when the ADH1 start sites
reside at their normal positions in the ADH1 promoter or when they are substituted at the position of their counterparts in the
HIS3 promoter.

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 6.
The differential effect of TFIIB mutations on the
ADH1 and HIS3 promoters is determined by the
promoter regions containing the respective transcription start sites.
(A) Schematic representation of the ADH1 and HIS3
promoter regions and the reciprocal HIS3-ADH1 and
ADH1-HIS3 hybrid promoters. The numbers indicate the
distances from the initiating ATG, and the arrows indicate the
positions of the major transcription start sites. (B) Primer extension
analyses were performed using a HIS3-specific primer and 30 µg of total RNA isolated from yeast strains containing the
ADH1 or HIS3-ADH1 promoter constructs and either
wild-type TFIIB or the indicated TFIIB mutant. (C) Primer extension
analyses were performed as described in the legend to panel B using
yeast strains containing the HIS3 or ADH1-HIS3
promoter constructs and either wild-type TFIIB or the indicated TFIIB
mutant.
|
|
In contrast to the nearly equal levels of the
23 and
10
HIS3 transcripts observed with the normal HIS3
promoter, fusion of the ADH1 sequences to the
HIS3 initiation region resulted in almost exclusive
utilization of the
23 start site, along with an expected increase in
the overall transcript levels (Fig. 6C, lanes 1 and 5). Moreover, the
positioning of the ADH1 TATA element 90 bp upstream of the
HIS3
23 site resulted in an increased amount of a minor
transcript that maps to HIS3 position
27 (Fig. 6C, lane
5). Importantly, no significant downstream shifts in initiation were
observed when either the HIS3 or the ADH1-HIS3
promoters were introduced into mutant TFIIB strains (Fig. 6C). Taken
together, the results from the hybrid promoter analyses suggest that
the sensitivity of the ADH1 and HIS3 promoters to
the effects of TFIIB mutations is determined by the sequences
surrounding their respective transcription start sites.
Base substitutions in the vicinity of transcription start sites can
alter their sensitivity to TFIIB mutations.
The preceding results
strongly suggest that the DNA sequence surrounding a transcription
start site determines whether that site is utilized to a lesser extent
in mutant TFIIB strains with a concomitant increase in the usage of
more-downstream sites. In light of these results, we addressed whether
base substitutions in the vicinity of a start site could alter the
sensitivity of that site to downstream shifts in mutant TFIIB strains.
As noted earlier, the ADH1
38 and
37 start sites and the
ADH1
28 and
27 start sites differ in their sensitivity
to TFIIB mutations, with the
38 and
37 sites being significantly
less utilized than the
28 and
27 sites in mutant TFIIB strains.
Comparison of the sequences encompassing the
38 and
37 start sites
and the
28 and
27 start sites revealed that all four start sites
reside within an identical 5-bp CAAGC motif (Fig.
7A). In contrast to the C that is
immediately upstream of the motif containing the
28 and
27 sites
(position
30), a T is present at the homologous position upstream of
the motif containing the
38 and
37 sites (position
40) (Fig. 7A).
To determine whether this base difference contributes to the
differential sensitivity of these sites to TFIIB mutations, a mutant
ADH1 promoter containing a T-to-C substitution at position
40 was constructed and analyzed. In a wild-type TFIIB strain, the
T(
40)C mutant promoter yielded a slightly higher amount of the
38
and
37 transcripts than the normal ADH1 promoter and
reduced levels of the
28 and
27 and further downstream minor transcripts (Fig. 7B, lanes 1 and 5). In mutant TFIIB strains, the
normal ADH1 promoter displayed the classical downstream
initiation pattern, yielding significantly reduced levels of the
38
and
37 transcripts relative to the
28 and
27 transcripts
accompanied by increased levels of the more downstream transcripts
(Fig. 7B, lanes 2 to 4). In contrast, the T(
40)C promoter yielded
nearly equal levels of the
38 and
37 transcripts and the
28 and
27 transcripts and significantly reduced levels of the
more-downstream transcripts (Fig. 7B, lanes 6 to 8). These results
suggest that the T(
40)C substitution increases utilization of the
38 and
37 sites in a wild-type TFIIB strain and renders these sites less sensitive to downstream shifts in mutant TFIIB strains.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 7.
Base substitutions in the vicinity of transcription
start sites can alter their sensitivity to TFIIB mutations. (A)
Presented is the DNA sequence of the transcription initiation regions
in the ADH1 and HIS3 promoters. Underlined in
bold is the CAPuGC motif present at both of the ADH1 start
sites and at the HIS3 23 start site. (B) Primer extension
analyses were performed as described in the legend to Fig. 6 using
yeast strains containing the ADH1 or T( 40)C mutant
ADH1 promoter constructs and either wild-type TFIIB or the
indicated TFIIB mutant. (C) Primer extension analyses were performed
using yeast strains containing the ADH1-HIS3 or G( 25)T
mutant ADH1-HIS3 promoter constructs and either wild-type
TFIIB or the indicated TFIIB mutant.
|
|
Having observed that the ADH1 T(
40)C substitution
conferred decreased sensitivity to the effects of TFIIB mutations, we
tested whether a base substitution in the vicinity of the
HIS3
23 start site could conversely confer increased
sensitivity to TFIIB mutations. As shown earlier, no significant
downstream shifts are observed with the HIS3
23 and
10
start sites. Examination of the sequence encompassing the
HIS3
23 start site revealed that it resides within the
sequence CAGGC, sharing homology with the CAAGC motif present at the
ADH1 start sites (Fig. 7A). Immediately upstream of this
motif, the HIS3
23 site contains a G at position
25, in
contrast to the T and C present immediately upstream of this motif at
the ADH1
38 and
37 sites and the ADH1
28
and
27 sites, respectively. Since the ADH1
38 and
37
start sites are sensitive to TFIIB mutations and contain a T
immediately upstream of the 5-bp motif, we tested whether substituting
a T at HIS3 position
25 could confer increased sensitivity
to TFIIB mutations. A variant ADH1-HIS3 promoter containing
the G(
25)T substitution was constructed, and the variant and normal
ADH1-HIS3 promoter constructs were introduced into wild-type
and mutant TFIIB strains. As seen earlier, the ADH1-HIS3
promoter exhibited almost exclusive utilization of the
23 site in the
wild-type TFIIB strain and yielded an extremely low level of the
10
transcript when introduced into the mutant TFIIB strains (Fig. 7C,
lanes 1 to 4). In contrast, the G(
25)T variant promoter yielded a
slightly increased level of the
10 transcript in the wild-type TFIIB
strain and exhibited significant downstream shifts in the mutant TFIIB
strains, with approximately equal levels of the
23 and
10
transcripts being observed in the E62G or V79L strains (Fig. 7C, lanes
5 to 8). These results indicate that the G(
25)T substitution renders
the HIS3
23 start site more sensitive to downstream shifts
in mutant TFIIB strains, and combined with the results from the variant
ADH1 T(
40)C promoter, demonstrate that the sensitivity of
transcription start sites to the effects of TFIIB mutations is
influenced by the DNA sequence immediately upstream.
The observation that the ADH1 T(
40)C substitution
increases the utilization of the
38 and
37 sites in a wild-type
TFIIB strain and renders these sites less sensitive to downstream
shifts in mutant TFIIB strains suggests that the sensitivity of start sites to the effects of TFIIB mutations may be correlated to the intrinsic strength of the start site. Alternatively, sensitivity may be
conferred by the identity of bases at specific positions in the
vicinity of the start site and not be strictly correlated to the
strength of the start site. To determine whether the sensitivity of a
start site to TFIIB mutations is dictated by overall strength or
specific sequences, 16 additional variant ADH1 promoters
that contained single-base substitutions upstream, downstream, or in the position of the
38 and
37 start sites (from positions
34 to
44) were constructed. Plasmids containing the normal or variant ADH1 promoters were introduced into a wild-type TFIIB strain
or the V79L mutant strain, and the transcripts were analyzed by primer extension and quantitated by phosphorimaging. In the wild-type TFIIB
strain, the
38 and
37 transcripts constituted 57% of the major
transcripts yielded by the normal ADH1 promoter (Fig. 8A and
C). Of the 17 substitutions analyzed, 3 significantly increased utilization of the
38 and
37 start sites in the wild-type TFIIB strain [T(
42)C (75%), T(
41)C (71%), and T(
40)C (72%)] and 8 decreased
38 and
37 utilization [A(
43)G (34%), C(
39)T (35%), A(
38)C (32%), A(
38)G (17%), A(
37)C (45%), A(
37)T (46%),
G(
36)T (34%), and C(
35)T (35%)], while 6 had minimal effects
[T(
44)C (57%), T(
40)A (61%), T(
40)G (59%), A(
38)T (53%),
A(
37)G (58%), and T(
34)C (61%)] (Fig. 8A and
C). In addition, the A(
38)C and A(
38)G substitutions conferred an altered initiation pattern at the
38 and
37 sites, abolishing utilization of the
38 start site and
creating a new start site at position
36 (Fig. 8A).

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 8.
The sensitivity of transcription start sites to TFIIB
mutations is determined by the sequence in the immediate vicinity of
the start sites and not by their intrinsic strength. Primer extension
analyses were carried out as described in the legend to Fig. 6 using
yeast strains containing the ADH1 or the indicated variant
ADH1 promoter construct and either wild-type TFIIB (A) or
the V79L TFIIB mutant (B). (C) Quantitation of 38 and 37 start site
utilization. Phosphorimaging and Molecular Analyst software were used
to quantitate ADH1 transcripts from three independent primer
extension analyses. Utilization of the 38 and 37 sites was plotted
as the percentage of major ADH1 transcripts ( 38 plus 37
divided by the sum of 38, 37, 28, and 27). The sensitivity
of the 38 and 37 sites to the effects of the V79L TFIIB mutation
was defined by the sensitivity index (S.I. = utilization of the 38
and 37 sites in the wild-type TFIIB strain divided by that in the
V79L strain).
|
|
In the V79L mutant TFIIB strain, the
38 and
37 transcripts
constituted 19% of the major transcripts yielded by the normal ADH1 promoter. We defined the sensitivity index (S.I.) of
the
38 and
37 sites in the normal ADH1 promoter as 3.0, corresponding to the ratio of their utilization in the wild-type strain
(57%) to that in the V79L strain (19%) (Fig. 8B and C). Substitutions that significantly decreased the sensitivity of the
38 and
37 sites
to the effects of the V79L TFIIB mutation included T(
40)G (S.I. = 1.7), T(
40)A (S.I. = 2.0), and T(
40)C (S.I. = 2.1) (Fig. 8B and C).
Surprisingly, introduction of the A(
38)G construct into the V79L
strain restored efficient
38 and
37 utilization, which had been
abolished when this construct was in the wild-type TFIIB strain (S.I. = 0.6) (Fig. 8). In addition, two substitutions significantly increased
the sensitivity of the start sites to the V79L TFIIB mutation
[A(
38)T (S.I. = 15.0) and A(
37)C (S.I. = 4.2)] (Fig. 8B and C).
Taken together, the results in Fig. 8 demonstrate that the sensitivity
of the ADH1
38 and
37 start sites to the effects of
TFIIB mutations is not correlated to the overall strength of the start
sites, but rather, is determined by the identity of bases at or in the
immediate vicinity of the start sites.
 |
DISCUSSION |
In this study we investigated the domain and residues of
S. cerevisiae TFIIB involved in the utilization of
transcription start sites and the underlying reason for why TFIIB
mutations cause downstream shifts in transcription initiation at some
but not other promoters. To identify residues of TFIIB involved in the
utilization of start sites, we modified the genetic approach of Hampsey
and coworkers to directly select for TFIIB mutants conferring
downstream shifts in transcription initiation in vivo (37). This approach resulted in the isolation of 24 sua7 alleles that conferred downstream shifts in
transcription initiation at the CYC1 and ADH1
promoters in vivo. The mutants contained single or multiple amino acid
substitutions in the highly conserved N-terminal region of the TFIIB
protein and in all cases involved a substitution for Glu-62, Arg-64,
Arg-78, or Val-79. Seventeen of the mutants, all with substitutions for
Arg-78 or Val-79, conferred a dominant phenotype for the ability to
grow on lactate in the presence of wild-type TFIIB. The remaining seven
mutants, all containing substitutions for Glu-62 or Arg-64, displayed a
recessive phenotype for growth on lactate medium. All of the mutants
also exhibited a cold-sensitive phenotype.
It is noteworthy that among the 15 mutants with multiple amino acid
substitutions, 5 of them contained substitutions of Tyr-30. Single-substitution mutants of Tyr-30 were not identified in the selection, but rather, these substitutions were always found in combination with a substitution of Arg-78 or Val-79. We think it
unlikely that these Tyr-30 substitutions are fortuitous for several
reasons. First, three different substitutions for this residue were
identified. Second, the Tyr-30 substitutions were always in combination
with an Arg-78 or Val-79 substitution. Third, in two cases the
Tyr-30/Arg-78 double-mutant strain grew better than the corresponding
Arg-78 mutant strain. Further work will be required to determine the
role of Tyr-30 in the function of both wild-type TFIIB and the Arg-78
and Val-79 mutant proteins.
In previous studies utilizing site-directed mutagenesis, we also
reported substitutions of residues Trp-63 and Phe-66 that conferred
downstream shifts in transcription initiation. Thus, substitutions of
residues Glu-62, Trp-63, Arg-64, Phe-66, Arg-78, or Val-79 have been
identified that confer downstream shifts in transcription initiation,
thereby defining a highly conserved discrete domain within the
N-terminal region of TFIIB involved in the utilization of start sites.
This domain is positioned adjacent and C terminal to a zinc-ribbon
motif in TFIIB that is required for stable RNAPII-TFIIB binding
(35). Continued biochemical analyses are needed to
determine the primary biochemical alteration associated with the mutant
TFIIB proteins.
As observed previously, TFIIB mutations conferred downstream shifts in
transcription initiation at the ADH1 and CYC1
promoters but not at the HIS3 promoter (Fig. 3). This
differential effect of TFIIB mutations on these promoters could be due
to differences in (i) the upstream regulatory regions, (ii) the TATA
elements, (iii) the spacing between the TATA elements and the start
sites, (iv) specific sequences between the TATA elements and the start sites, and/or (v) specific sequences in the immediate vicinity of the
start sites. To shed light on the mechanism by which TFIIB influences
the utilization of start sites, we sought to exploit the
promoter-specific effect of the TFIIB mutations and determine which of
the above promoter features renders the ADH1 and
HIS3 promoters sensitive and insensitive, respectively, to
TFIIB mutations. We initially examined whether the distance between the
TATA element and the start sites plays a role in establishing the
sensitivity of those sites to TFIIB mutations. Analysis of a series of
ADH1 promoters containing insertions or deletions between
the TATA element and the initiation region demonstrated that alteration in the spacing of this region had no significant effect on the sensitivity of this promoter to TFIIB mutations (Fig. 5). A
sequence-dependent basis for the differential sensitivity to TFIIB
mutations was initially suggested by the observation that the
ADH1
38 and
37 start sites and the ADH1
28
and
27 start sites, separated by only 10 bp, differ in their
sensitivity to TFIIB mutations (Fig. 4). Results from the analysis of
reciprocal HIS3-ADH1 and ADH1-HIS3 hybrid
promoters supported this view, demonstrating that the differential sensitivity of the HIS3 and ADH1 promoters to
TFIIB mutations was not due to differences in promoter architecture or
sequences far upstream of the start sites, but rather was due to
differences in the specific sequences in the immediate vicinity of the
respective start sites (Fig. 6). Examination of the sequence of the
ADH1 and HIS3 start sites revealed that the
ADH1
38 and
37 sites and the ADH1
28 and
27 sites reside within a CAAGC motif while the HIS3
23
site is contained within the sequence CAGGC, both sharing homology with
a PyAA/TPu proposed consensus sequence for S. cerevisiae
RNAPII start sites (14, 20, 22). The suggestion that the
differential sensitivity of these start sites to TFIIB mutations is due
to sequence differences in the immediate vicinity of the sites was
further supported by the demonstration that a T(
40)C substitution
conferred decreased sensitivity of the ADH1
38 and
37
sites to TFIIB mutations, whereas a G(
25)T substitution rendered the
HIS3
23 start site more sensitive (Fig. 7).
The preceding results demonstrated that base substitutions in the
immediate vicinity of start sites could alter their sensitivity to
TFIIB mutations. However, since the ADH1 T(
40)C
substitution rendered the
38 and
37 start sites less sensitive to
downstream shifts in mutant TFIIB strains but also modestly increased
their utilization in a wild-type TFIIB strain, it was unclear whether the sensitivity of start sites to TFIIB mutations was dictated by
specific sequences or simply by the intrinsic strength of the start
site. The analysis of 16 additional variant ADH1
promoters containing single-base substitutions upstream, downstream, or in the position of the
38 and
37 start sites demonstrated that sensitivity was not correlated with overall strength, but rather was
dictated by the identity of bases at or in the immediate vicinity of
the start sites (Fig. 8). This was evidenced by (i) the T(
42)C substitution, which conferred the highest utilization of the
38 and
37 sites in a wild-type TFIIB strain yet the same degree of
sensitivity seen for the normal ADH1 promoter (S.I. = 3.0) in the V79L mutant TFIIB strain; (ii) the T(
40)A, T(
40)C, and T(
40)G substitutions, which conferred little or no change in
38 and
37 utilization in the wild-type strain but decreased sensitivity
(S.I. = 1.7 to 2.1) in the V79L strain; (iii) the A(
38)T
substitution, which conferred no change in
38 and
37 usage in the
wild-type strain yet dramatically increased sensitivity in the V79L
strain (S.I. = 15); and (iv) the A(
38)G substitution, which abolished
utilization of the
38 site in the wild-type strain yet surprisingly
supported efficient utilization in the V79L strain. The last result
also provides the first example of a start site sequence that is
utilized preferentially in a mutant TFIIB strain, suggesting that TFIIB
mutations may not only impair normal start site recognition by RNAPII
but also confer altered specificity as well.
As noted earlier, transcription initiation in higher eukaryotes usually
occurs at a discrete site located about 30 bp downstream of the TATA
element, whereas transcription initiation in S. cerevisiae often occurs at multiple sites within a window of 45 to 120 bp downstream of the TATA element. The ability of S. cerevisiae
RNAPII to initiate within an extended window downstream of the TATA
element reflects a fundamental difference in the initiation mechanism compared to that in higher eukaryotic cells, and the basis for this
difference is unknown. Thus, it remains of significant interest to
determine both the mechanism by which S. cerevisiae RNAPII initiates transcription at such a distance from the TATA element and
the manner in which wild-type and mutant forms of TFIIB affect the
utilization of potential start sites. One possibility to account for
the difference in the mammalian and yeast initiation patterns is that
the positioning of yeast PICs on a promoter is fundamentally different
from that of mammalian PICs. Yeast PICs could potentially adopt a much
more elongated conformation than mammalian PICs and/or loop out
intervening DNA in order to contact downstream start sites. Although
this remains a possibility, it has been reported that promoter melting
for the S. cerevisiae GAL1 and GAL10 genes in
vivo is comparable to that seen in other eukaryotes, occurring approximately 20 bp downstream of the TATA element (15).
Moreover, the extent of melting was reported to be independent of the
distance between the TATA element and the transcription start sites.
Thus, the positioning and promoter melting of yeast PICs appears to be
similar to that of mammalian PICs. In light of these results, Giardina
and Lis proposed that S. cerevisiae RNAPII may be released from the PIC and scan downstream DNA for preferred start sites (15).
Results from both genetic and biochemical studies strongly suggest that
RNAPII and TFIIB are solely responsible for determining the start site
of transcription in S. cerevisiae. Genetic studies have
shown that mutations in the largest subunit of RNAPII (Rpb1) can confer
downstream shifts in transcription initiation that are similar to those
observed with TFIIB mutations (6). In contrast, deletion
of the Rpb9 subunit of RNAPII, or mutation disrupting a C-terminal
zinc-ribbon in Rpb9, confers an upstream shift in transcription
initiation (23, 46). Biochemical studies by Kornberg and
colleagues have shown that the pairwise exchange of S. cerevisiae TFIIB and RNAPII with their homologs from
Schizosaccharomyces pombe is sufficient to convert the
transcription initiation pattern to that of S. pombe
(27). Thus, an attractive extension to the scanning model
is that a TFIIB-RNAPII interaction governs the start site recognition
properties of RNAPII and that TFIIB mutants confer downstream shifts in
transcription initiation by impairing start site recognition. Initially
proposed by Hampsey and colleagues, such impairment could cause RNAPII
to bypass sites normally used for initiation and allow for initiation
at sites further downstream (38). Our results here
demonstrate that the sequence at or in the immediate vicinity of a
start site determines the tendency of that site to be underutilized in
mutant TFIIB strains accompanied by increased usage of further
downstream start sites. These results are consistent with the view that
a TFIIB-RNAPII functional interaction, either direct or through the
action of another factor, affects the efficiency by which potential
start sites are recognized and utilized by a scanning polymerase. The
incorporation of TFIIB mutants into additional genetic, biochemical,
and molecular studies should prove useful in determining the precise
mechanism by which S. cerevisiae RNAPII recognizes and
utilizes potential transcription start sites.
This work was supported by a grant from National Science Foundation
(MCB-9905418) and a Public Health Service grant from the National
Institutes of Health (GM51124) to A.S.P.
| 1.
|
Aiyar, A., and J. Leis.
1993.
Modification of the megaprimer method of PCR mutagenesis: improved amplification of the final product.
BioTechniques
14:366-367[Medline].
|
| 2.
|
Bagby, S.,
S. Kim,
E. Maldonado,
K. I. Tong,
D. Reinberg, and M. Ikura.
1995.
Solution structure of the C-terminal core domain of human TFIIB: similarity to cyclin A and interaction with TATA-binding protein.
Cell
82:857-867[CrossRef][Medline].
|
| 3.
|
Bangur, C. S.,
T. S. Pardee, and A. S. Ponticelli.
1997.
Mutational analysis of the D1/E1 core helices and the conserved N-terminal region of yeast transcription factor IIB (TFIIB): identification of an N-terminal mutant that stabilizes TATA-binding protein-TFIIB-DNA complexes.
Mol. Cell. Biol.
17:6784-6793[Abstract].
|
| 4.
|
Barberis, A.,
C. W. Muller,
S. C. Harrison, and M. Ptashne.
1993.
Delineation of two functional regions of transcription factor TFIIB.
Proc. Natl. Acad. Sci. USA
90:5628-5632[Abstract/Free Full Text].
|
| 5.
|
Berroteran, R. W., and M. Hampsey.
1991.
Genetic analysis of yeast iso-1-cytochrome c structural requirements: suppression of Gly6 replacements by an Asn52 Ile replacement.
Arch. Biochem. Biophys.
288:261-269[CrossRef][Medline].
|
| 6.
|
Berroteran, R. W.,
D. E. Ware, and M. Hampsey.
1994.
The sua8 suppressors of Saccharomyces cerevisiae encode replacements of conserved residues within the largest subunit of RNA polymerase II and affect transcription start site selection similarly to sua7 (TFIIB) mutations.
Mol. Cell. Biol.
14:226-237[Abstract/Free Full Text].
|
| 7.
|
Boeke, J. D.,
J. Trueheart,
G. Natsoulis, and G. R. Fink.
1987.
5-Fluoroorotic acid as a selective agent in yeast molecular genetics.
Methods Enzymol.
154:164-175[Medline].
|
| 8.
|
Buratowski, S., and H. Zhou.
1993.
Functional domains of transcription factor TFIIB.
Proc. Natl. Acad. Sci. USA
90:5633-5637[Abstract/Free Full Text].
|
| 9.
|
Bushnell, D. A.,
C. Bamdad, and R. D. Kornberg.
1996.
A minimal set of RNA polymerase II transcription protein interactions.
J. Biol. Chem.
271:20170-20174[Abstract/Free Full Text].
|
| 10.
|
Chiang, Y. C.,
P. Komarnitsky,
D. Chase, and C. L. Denis.
1996.
ADR1 activation domains contact the histone acetyltransferase GCN5 and the core transcriptional factor TFIIB.
J. Biol. Chem.
271:32359-32365[Abstract/Free Full Text].
|
| 11.
|
Colgan, J.,
H. Ashali, and J. L. Manley.
1995.
A direct interaction between a glutamine-rich activator and the N terminus of TFIIB can mediate transcriptional activation in vivo.
Mol. Cell. Biol.
15:2311-2320[Abstract].
|
| 12.
|
Fang, S. M., and Z. F. Burton.
1996.
RNA polymerase II-associated protein (RAP) 74 binds transcription factor (TF) IIB and blocks TFIIB-RAP30 binding.
J. Biol. Chem.
271:11703-11709[Abstract/Free Full Text].
|
| 13.
|
Franklin, C. C.,
A. V. McCulloch, and A. S. Kraft.
1995.
In vitro association between the Jun protein family and the general transcription factors, TBP and TFIIB.
Biochem. J.
305:967-974.
|
| 14.
|
Furter-Graves, E. M., and B. D. Hall.
1990.
DNA sequence elements required for transcription initiation of the Schizosaccharomyces pombe ADH gene in Saccharomyces cerevisiae.
Mol. Gen. Genet.
223:407-416[Medline].
|
| 15.
|
Giardina, C., and J. T. Lis.
1993.
DNA melting on yeast RNA polymerase II promoters.
Science
261:759-762[Abstract/Free Full Text].
|
| 16.
|
Goodrich, J. A.,
T. Hoey,
C. J. Thut,
A. Admon, and R. Tjian.
1993.
Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB.
Cell
75:519-530[CrossRef][Medline].
|
| 17.
|
Guarente, L.
1987.
Regulatory proteins in yeast.
Annu. Rev. Genet.
21:425-452[CrossRef][Medline].
|
| 18.
|
Ha, I.,
S. Roberts,
E. Maldonado,
X. Sun,
L. U. Kim,
M. Green, and D. Reinberg.
1993.
Multiple functional domains of human transcription factor IIB: distinct interactions with two general transcription factors and RNA polymerase II.
Genes Dev.
7:1021-1032[Abstract/Free Full Text].
|
| 19.
|
Hadzic, E.,
V. Desai-Yajnik,
E. Helmer,
S. Guo,
S. Wu,
N. Koudinova,
J. Casanova,
B. M. Raaka, and H. H. Samuels.
1995.
A 10-amino-acid sequence in the N-terminal A/B domain of thyroid hormone receptor alpha is essential for transcriptional activation and interaction with the general transcription factor TFIIB.
Mol. Cell. Biol.
15:4507-4517[Abstract].
|
| 20.
|
Hahn, S.,
E. T. Hoar, and L. Guarente.
1985.
Each of three "TATA elements" specifies a subset of transcription initiation sites at the CYC1 promoter of Saccharomyces cerevisiae.
Proc. Natl. Acad. Sci. USA
82:8562-8566[Abstract/Free Full Text].
|
| 21.
|
Hampsey, M.,
J. G. Na,
I. Pinto,
D. E. Ware, and R. W. Berroteran.
1991.
Extragenic suppressors of a translational initiation defect in the cyc1 gene of Saccharomyces cerevisiae.
Biochimie
73:1445-1455 |